Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

10805	Companies
233872	Keywords
162569	Articles
124909	Press releases

Home
Companies
Biophytis

BRIEF

published on 08/03/2026 at 07:05, 2 days 18 hours ago

Biophytis Updates on Hong Kong Joint Venture Progress

Biophytis Joint Venture Clinical Trial Sarcopenia BIO101
REGULATED PRESS RELEASE

published on 08/03/2026 at 07:00, 2 days 18 hours ago

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Biophytis provides an update on its Hong Kong joint venture, including intellectual property transfer, funding details, and clinical trial preparations

Biophytis Joint Venture Hong Kong Intellectual Property Clinical Trial
PRESS RELEASE

published on 08/03/2026 at 06:59, 2 days 18 hours ago

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Biophytis provides an update on its Hong Kong joint venture, including key milestones achieved and imminent progress. The joint venture aims to develop BIO101 for sarcopenia in Asian markets

Biophytis Joint Venture Hong Kong Sarcopenia BIO101
BRIEF

published on 07/29/2026 at 23:05, 7 days 2 hours ago

Biophytis Reports Audited 2025 Financial Results and Stock Trading Resumption

Financial Results Biophytis Trading Resumption 2025 Audit Funding Uncertainty
REGULATED PRESS RELEASE

published on 07/29/2026 at 23:00, 7 days 2 hours ago

BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock. The company's financial debt and current liabilities decreased by 5% compared to 2024

Financial Statements Biophytis Financial Debt Trading Resumption Liabilities
PRESS RELEASE

published on 07/29/2026 at 22:59, 7 days 2 hours ago

BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock. The company's financial debt and current liabilities decreased by 5% in 2025. Net loss improved by 13% compared to 2024

Financial Statements Biophytis Trading Net Loss Financial Debt
BRIEF

published on 07/01/2026 at 07:05, 1 month 4 days ago

Biophytis Reports 2025 Financial Outcomes and Strategic Plans

Regulatory Milestones Asian Joint Venture Biophytis Financial Results Sarcopenia Clinical Trials Cash Flow Uncertainty
REGULATED PRESS RELEASE

published on 07/01/2026 at 07:00, 1 month 4 days ago

BIOPHYTIS REPORTS ITS PROVISIONAL FINANCIAL RESULTS AND PROVIDES ITS STRATEGIC OUTLOOK
Biophytis reports provisional financial results for fiscal year 2025 and strategic outlook, including milestones in sarcopenia and obesity programs, engagement with scientific community, and financial restructuring

Biophytis Sarcopenia Obesity Strategic Outlook Provisional Financial Results
BRIEF

published on 06/15/2026 at 23:05, 1 month 20 days ago

Biophytis Temporarily Suspends Share Trading

Biophytis Financial Report Euronext Growth Share Suspension Operational Delay
REGULATED PRESS RELEASE

published on 06/15/2026 at 23:00, 1 month 20 days ago

BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Biophytis announces temporary suspension of share trading on Euronext due to delay in financial report, expected to resume by end of July 2026

Biophytis Euronext Financial Report Suspension Share Trading

Accesswire

Published on 08/06/2026 at 01:40, 15 minutes ago

Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor
Published on 08/05/2026 at 23:40, 2 hours 15 minutes ago

Galantas Gold Secures Key Permitting Approvals for Andacollo Gold Project
Published on 08/05/2026 at 23:10, 2 hours 45 minutes ago

Ur-Energy Announces Date for Second Quarter 2026 Results and Conference Call and Webcast
Published on 08/05/2026 at 23:01, 2 hours 54 minutes ago

Full Circle Lithium Announces Extension of Current Private Placement
Published on 08/05/2026 at 23:00, 2 hours 55 minutes ago

Pentagon I Capital Corp. Announces Filing of Filing Statement with Respect to Its Qualifying Transaction

View all ACCESSWIRE

EQS Group

Published on 08/05/2026 at 23:23, 2 hours 31 minutes ago

EQS-Adhoc: Enapter AG: Agreement with Patrimonium to discharge corporate bond liabilities of around EUR 26 million; realignment to an asset-light business model; capital measure planned
Published on 08/05/2026 at 23:04, 2 hours 50 minutes ago

AUTODOC to publish H1 2026 report and host a conference call on Q2 results on 13 August 2026
Published on 08/05/2026 at 19:14, 6 hours 41 minutes ago

2CRSi informs the market about the governance of AETHER Infrastructures and the progress of the AETHER project in which 2CRSi takes part as a member of the consortium
Published on 08/05/2026 at 18:45, 7 hours 10 minutes ago

Holding(s) in Company
Published on 08/05/2026 at 18:30, 7 hours 24 minutes ago

Avolta enters Kolkata Airport, growing duty-free presence in India

Les Echos

Published on 08/05/2026 at 18:00, 7 hours 55 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 8 hours 5 minutes ago

Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 8 hours 10 minutes ago

Information concerning the total number of voting rights and shares 2026 07 31
Published on 08/05/2026 at 17:45, 8 hours 10 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 08/05/2026 at 17:42, 8 hours 13 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 July 2026

View all LES ECHOS COMFI WIRE